Cardiomatics, the cloud AI tool that allows any trained medical staff to carry out electrocardiogram (ECG) analysis, has raised US$3.2 million in seed funding led by KAYA, the Central and Eastern European VC which has backed companies including Rohlik, Booksy, and DocPlanner.
Nina Capital, Nova Capital and Innovation Nest also participated in the round, which includes a US$1m non-equity grant from the Polish National Centre of Research and Development. Cardiomatics will use the funding to invest in product development, business activities in existing markets, and prepare the product to launch into new markets.
In a press release, Cardiomatics said it is democratising access to cardiac diagnoses, allowing any healthcare professional to read and understand an ECG test. Doctors can use the tool to detect and analyse many heart abnormalities, detect different heart disorders, and clearly visualise beats and rhythms in the recording. It takes minutes between a test to get the full report.
Already, over 3 million hours of ECG signals have been analysed commercially by the AI tool. It is used on a daily basis by more than 700 customers in 10+ countries, including Switzerland, Denmark, Germany and Poland. The tool received European medical device certification in 2018.